On September 15, Avanos Medical, Inc. announced the acquisition of Nexus Medical, LLC for an undisclosed price.
Nexus Medical is a Lenexa, Kansas-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. Nexus is renowned for its TKO anti-reflux needleless connector technology, which enhances the safety and consistency of nutrition and medication delivery, particularly in high-acuity settings like neonatal and pediatric intensive care units.
Avanos Medical is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients’ quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today’s most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries. According to its 2024 annual report, Avanos’s revenue during FY 2024 was $687.8 million.
The acquisition was funded using Avanos’ available cash reserves. It is expected to positively impact Avanos’ revenue growth and earnings per share.
According to data captured in the LevinPro HC database, this marks the 64th Medical Device transaction of 2025. There were 87 Medical Device deals announced during 2024, 112 announced in 2023 and 124 announced during 2022.
